Company News

Gan & Lee Pharmaceuticals Attends the 19th CPhI & P-MEC China

  • Time: 2019-08-09 13:39:13
  • Click Rate: 6351


The 19th Chemical Pharmaceutical Ingredient Exhibition China (CPhI China) has been successfully completed in Shanghai New International Expo Center. The 3-day exhibition from June 18th to 20th, covering an area of 200,000 square meters, has attracted over 3,200 high-quality suppliers from both domestic and foreign markets, including 20 overseas companies. The exhibition has been subdivided into 13 plates, including pharmaceutical raw materials, pharmaceutical excipients, pharmaceutical preparation, Biopharmaceutical, pharmaceutical machinery, pharmaceutical logistics, etc. More than 70,000 professional audiences from 120 countries and regions have gathered.


As a pharmaceutical enterprise with a sense of mission, Gan & Lee Pharmaceuticals has been listed in 12 countries on four continents. In the regulatory countries, such as Europe and the United States, products are also in the clinical trial and registration stages, which are expected to be approved for launching in the very near future. Meanwhile, Gan & Lee is continually expanding its product lines to cover diabetes, blood diseases, tumors and many other fields of drugs. This was the sixth time Gan & Lee attended the CPhI China in Shanghai as an exhibitor.  

Based on the multi-channel marketing model including, but not limited to, video presentation, sample display and brochure introduction, the exhibition comprehensively and profoundly showed the corporate image of science and perfection in our products, brand, company culture, global strategic management, etc. Approximately 1,000 attendees from all over the world visited, while engaging with the Gan & Lee team for further information and details.


During the exhibition, Guoyi Xian, Director of Service and Trade, Ministry of Commerce, China, together with his colleagues, inspected the Gan & Lee booth and had further communications with Tongjia Wu, Director of International Department, to get a better understanding of the industry. Tongjia Wu introduced the global business development and targets from the international aspect of strategic development. Satisfactorily, Gan & Lee received unanimous praise from Guoyi Xian and his colleagues.

Under the trend of increasingly fierce international competition, Gan & Lee will keep the enterprise spirit of science and perfection, comprehensively developing drug products in diabetes, blood diseases, tumors and other fields, with a devotion to improving the lives of patients around the world.